Three Xarelto lawsuits are headed to trial starting next month in the Philadelphia Court of Common Pleas, the home of a mass tort program that includes more than 1,700 product liability claims involving the controversial blood-thinning medication. (In Re: Xarelto Litigation, Case No. 150102349)
Pennsylvania concluded its first Xarelto trial late last year, when a Philadelphia jury awarded $28 million in compensatory and punitive damages to an Indiana woman who suffered a gastrointestinal bleed after taking the medication for a little over a year. However, the trial court dismissed the verdict in January, after finding that the evidence presented was insufficient to justify the massive award.